A Clinical Study Of Effect Of Vrikshamla With Shuddha Guggulu In Hyperlipidaemia With Special Reference To Medovriddhi
Phase 2/3
Not yet recruiting
- Conditions
- Hyperlipidemia, unspecified. Ayurveda Condition: MEDOVRUDDHIH,
- Registration Number
- CTRI/2025/04/085379
- Lead Sponsor
- Dr MRUNALI SHRIRANG BHARATE
- Brief Summary
This study is Randomized,Controlled,Clinical, study of add on effect of vrikshmla 500mg bd with guggulu 1gm bd for 30days in pateints of medovridhi with special reference to hyperlipidemia .This study is conducted as PG course at single centre. The primary outcome is to evaluate the effect of vrikshmla on hyperlipidemia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Patients as per above diagnostic criteria 2.
- Age between 18 to 60 yrs of either gender.
- Patients BMI between 25 to 35 4.
- Patient willing for trial, irrespective of socioeconomic condition.
Exclusion Criteria
- Pregnant females and lactating mothers.
- Subjects suffering from any critical illness that is cardiovascular diseases, renal impairments.
- Subjects not willing for trial.
- Patients on Glucocorticoids, statins 5.
- Patients with uncontrolled diabetes mallitus.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the add on effect of Vrikshamla with Shuddha guggulu on - 30 days Serum total Cholesterol 30 days Serum Triglycerides 30 days Serum High density lipoprotein 30 days Serum Low Density 30 days Serum very low density lipoprotein 30 days
- Secondary Outcome Measures
Name Time Method To study the add on effect of Vrikshamla with Shuddha guggulu on - BMI
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Vrikshamla and Shuddha Guggulu's lipid-lowering effects in Medovriddhi?
How does the combination of Vrikshamla and Shuddha Guggulu compare to statins in managing hyperlipidemia?
Are there specific biomarkers that predict response to Vrikshamla in Ayurvedic Medovriddhi patients?
What are the potential adverse events associated with Vrikshamla and Shuddha Guggulu in lipid management?
What other Ayurvedic compounds or combination therapies show promise in treating hyperlipidemia and Medovriddhi?
Trial Locations
- Locations (1)
Government Ayurvedic college and Hospital, Nanded
🇮🇳Nanded, MAHARASHTRA, India
Government Ayurvedic college and Hospital, Nanded🇮🇳Nanded, MAHARASHTRA, IndiaDR MRUNALI SHRIRANG BHARATEPrincipal investigator09130404633mrunalibharate7@gmail.com